Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: ritlecitinib

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By
Prof. Melissa Piliang, Cleveland Clinic, OH, USA
Trial
Phase 3, ALLEGRO
Conference
WCD 2023

31 August, 2023 15:18

The rise of JAK inhibitors for alopecia areata

Presented By
Dr Brett King, Yale University, CT, USA
Conference
DDD 2023

10 May, 2023 13:47

Start low with brepocitinib and ritlecitinib in UC

Presented By
Dr Kenneth Hung, Pfizer, MA, USA
Trial
Phase 2, VIBRATO
Conference
UEGW 2022

1 December, 2022 21:34

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By
Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany
Trial
Phase 3, ALLEGRO-LT
Conference
EADV 2022

5 November, 2022 09:30

EADV 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
EADV 2022

27 September, 2022 11:49

Light at the end of the tunnel for vitiligo therapy

Presented By
Dr David Rosmarin, Tufts Medical Center, USA
Trial
Phase 3, TRuE-V1; TRuE-V2
Conference
AAD 2022

17 May, 2022 11:05

Novel JAK3/TEC blocker leads to maintained re-pigmentation in vitiligo

Presented By
Prof. Khaled Ezzedine, University Hospital Henri Mondor, France
Trial
Phase 2
Conference
EADV 2021

18 November, 2021 13:32

Alopecia areata: encouraging response rates with JAK3/TEC inhibition

Presented By
Prof. Brett King, Yale University School of Medicine, USA
Trial
ALLEGRO
Conference
EADV 2021

18 November, 2021 13:11

Ritlecitinib and brepocitinib are promising JAK inhibitors for UC

Presented By
Dr William Sandborn, University of California San Diego, CA, USA
Trial
Phase 2, VIBRATO
Conference
UEGW 2021

27 October, 2021 09:53
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy